1.
Serum levels of oxidative stress marker malondialdehyde in breast cancer patients in relation to pathohistological factors, estrogen receptors, menopausal status, and age. JHSCI [Internet]. 2018 Dec. 18 [cited 2024 May 9];8(3):154-61. Available from: https://www.jhsci.ba/ojs/index.php/jhsci/article/view/263